Cancer Research The Future of Cancer Research: Science and Patient Impact
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 29, 1721-1731, September 1, 1969]
© 1969 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fogh, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fogh, J.

Reduced Tumor-producing Capacity of Mycoplasma-modified Lines of FL Human Amnion Cells in the Cheek Pouch of Cortisonized Hamsters1

Jørgen Fogh

Division of Experimental Pathology, Sloan-Kettering Institute for Cancer Research, New York, New York 10021

Long-term mycoplasma (Strain HT) infection of cells of the FL line of human amnion has distinctly reduced their tumor-producing capacity in the cheek pouch of cortisonized weanling golden Syrian hamsters. The number of cells necessary for tumor production (TPD50) was increased in the order 5 to 10 times, as compared to uninfected FL cells, for three different cell lines originating from independent experiments (F 138, F 159, HTP8). An apparent increase in average tumor volume observed for these mycoplasma-infected cell lines was not an expression of high rate of growth of the tumor cells but was the result of the concurrent infection. After elimination of mycoplasma from the cell lines in vitro (F 138cl, F 159cl, HTP8cl), the change in TPD50 was maintained, even after one year; the size of tumor resulting from a certain inoculum was reduced, and regression occurred earlier in comparison with the results obtained with the uninfected FL cells. Correlated with the previously reported changes in the in vitro behavior and chromosomal constitution of these mycoplasma-modified cell lines, the present in vivo results add further support to the degrading of the malignant state of FL human amnion cells accomplished by long-term mycoplasma infection.

1 This investigation was supported in part by National Cancer Institute Grant No. CA-08748.

Received 7/ 3/68. Accepted 5/12/69.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1969 by the American Association for Cancer Research.